1KITO H,SUZUKI H, IGARASHI T, et al. Distinct patterns of cromosomal losses in clinically synchronous and asynchronous bi- lateral renal cell carcinoma [J]. J Urol, 2002,168 : 2637-2640.
2BLUTE ML, AMLING CL, BRYANT SC, et al. Management and extended outcome of patients with synchronous bilateral sol- id renal neoplasms in the absence of yon Hippel-Lindau disease [J]. Mayo Clin Proc, 2000,75 : 1020-1026.
3JASON ROTHMAN, CRISPEN PL, et al. Pathologic concord- ance of sporadic synchronous bilateral renal masses [J]. Urolo- gy,2008,72 : 138-142.
4PAOLA DAL CIN, LTEIN VAN POPPEI. Cytogenetic investi- gation of synchronous bilateral renal tumors cytogenetic investi- gation of synchronous bilateral renal tumors[J]. Cancer Gene Cytogenet, 1996,89 : 57-50.
6SIMMONS MN, WEIGHT CJ, GILL IS. Laparoscopic radical versus partial nephrectomy for tu tumors>4 cm: intermediate- term oncologic and functional outcomes[J]. Urology, 2009,73 : 1077.
7SIMMONS MN, RICARDO BRANDINA. Surgical management of bilateral synchronous kidney tumors: functional and oncologi- cal outcomes[J]. J Urol, 2010,184 (3): 865-872.
10FRANK BECKER, STEFAN SIEME. Long-term Survival in bi- lateral renal cell carcinoma: A retrospective single-institutional analysis of 101 patients after surgical treatment[J]. Urology, 2008,72: 349-353.
二级参考文献25
1Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Sur veillance, Epidemiology, and End Results program. J Urol, 2006, 176: 2397-2400.
2Huang WC, Levey AS, Serio AM, et al. Chronic kidney dis ease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol, 2006, 7, 735-740.
3Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N EnglJ Med, 2004, 351:1296 -1305.
4Mathew A, Devesa SS, Fraumeni JF Jr, et al. Global increa ses in kidney cancer incidence, 1973 1992. Eur J Cancer Prey, 2002, ll: 171-178.
5Porter MP, Lin DW. Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urol Oncol, 2007, 25: 298-302.
6Zini L, Patard JJ, Capitanio U, et al. The use of partial ne phrectomy in European tertiary care centers. Eur J Surg On col, 2009, 35: 636-642.
7Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol, 2001, 166:6- 18.
8Fergany AF, Hafez KS, Novick AC. Long term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol, 2000, 163:442- 445.
9Becker F, Siemer S, Humke U, et al. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long term survival data of 216 patients. Eur Urol, 2006, 49:308- 313.
10Zini L, Perrotte P, Capitanio U, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer, 2009, 115:1465 -1471.
2Oncologic Long-term Outcome of Elective Nephron-sparing Surgery Versus Radical Nephrectomy in Patients With Renal Cell Carcinoma Stage pT1b or Greater in a Matched-pair Cohort[J]. Urology . 2011 (4)
